Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

This study has been terminated.

(Lack of funding)

Sponsor:

Collaborator:

Sanofi

Information provided by:

Capital District Health Authority, Canada

ClinicalTrials.gov Identifier:

NCT00688948

First received: May 30, 2008

Last updated: June 23, 2011

Last verified: February 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	November 2009
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)